| 25/06/21 | NattoPharma ASA : - Delisting | AQ |
| 15/06/21 | NattoPharma : Received application for delisting | AQ |
| 14/06/21 | NattoPharma : Annual General Meeting in NattoPharma ASA | AQ |
| 10/06/21 | NattoPharma : OSLO BØRS - SUSPENDED | AQ |
| 09/06/21 | NattoPharma ASA: Compagnie des Levures Lesaffre announces compulsory acquisition | AQ |
| 1 day | +2.35% |
| Manager | Title | Age | Since |
|---|---|---|---|
Kjetil Ramsøy
CEO | Chief Executive Officer | 54 | 07/02/2018 |
Robert Schrama
DFI | Director of Finance/CFO | - | 08/03/2020 |
Gunilla Traberg
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Frode Marc Bohan
CHM | Chairman | 58 | 03/11/2004 |
| Director/Board Member | 52 | 31/01/2011 | |
Kjetil Ramsøy
BRD | Director/Board Member | 54 | 31/12/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.35% | +1.46% | - | - | 86.2M | |
| +0.37% | +1.95% | +63.47% | +118.14% | 1,055B | |
| +0.25% | +1.01% | +49.86% | +73.50% | 654B | |
| +1.04% | +0.87% | +19.55% | +75.23% | 467B | |
| -1.36% | -2.58% | +38.77% | +42.33% | 348B | |
| +1.34% | +4.53% | +22.56% | +29.55% | 275B | |
| -0.48% | -0.54% | +12.66% | +13.50% | 258B | |
| +0.77% | +6.13% | +52.30% | +54.08% | 224B | |
| +0.86% | +0.94% | +34.94% | +101.50% | 187B | |
| -0.30% | -2.98% | -28.24% | -61.28% | 171B | |
| Average | +0.49% | +0.74% | +29.54% | +49.62% | 404.26B | |
| Weighted average by Cap. | +0.27% | +1.32% | +39.88% | +70.03% |
Employees
18
Sector
Pharmaceuticals
